NxStage Medical Revenue 2006-2018 | NXTM

NxStage Medical revenue from 2006 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
NxStage Medical Annual Revenue
(Millions of US $)
2017 $394
2016 $366
2015 $336
2014 $302
2013 $263
2012 $242
2011 $217
2010 $179
2009 $149
2008 $129
2007 $60
2006 $21
2005 $6
NxStage Medical Quarterly Revenue
(Millions of US $)
Q3 2018 $108
Q2 2018 $107
Q1 2018 $107
Q4 2017 $104
Q3 2017 $97
Q2 2017 $96
Q1 2017 $97
Q4 2016 $93
Q3 2016 $92
Q2 2016 $92
Q1 2016 $89
Q4 2015 $90
Q3 2015 $87
Q2 2015 $80
Q1 2015 $79
Q4 2014 $80
Q3 2014 $75
Q2 2014 $74
Q1 2014 $72
Q4 2013 $69
Q3 2013 $67
Q2 2013 $65
Q1 2013 $62
Q4 2012 $65
Q3 2012 $61
Q2 2012 $59
Q1 2012 $57
Q4 2011 $57
Q3 2011 $56
Q2 2011 $54
Q1 2011 $51
Q4 2010 $50
Q3 2010 $45
Q2 2010 $44
Q1 2010 $40
Q4 2009 $41
Q3 2009 $38
Q2 2009 $36
Q1 2009 $34
Q4 2008 $36
Q3 2008 $30
Q2 2008 $32
Q1 2008 $31
Q4 2007 $30
Q3 2007 $12
Q2 2007 $10
Q1 2007 $8
Q4 2006 $7
Q3 2006 $6
Q2 2006 $5
Q1 2006 $3
Q4 2005 $2
Q3 2005 $1
Q2 2005 $1
Q1 2005 $1
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.977B $0.394B
NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $131.725B 26.04
Medtronic (MDT) Ireland $124.003B 18.10
Stryker (SYK) United States $69.357B 25.46
Boston Scientific (BSX) United States $55.158B 26.93
Baxter (BAX) United States $39.096B 24.09
Zimmer Biomet Holdings (ZBH) United States $25.203B 16.17
Smith & Nephew SNATS (SNN) United Kingdom $16.703B 0.00
ResMed (RMD) United States $14.294B 27.11
Canopy Growth (CGC) Canada $10.770B 0.00
Bio-Rad Laboratories (BIO) United States $8.091B 51.74
Hill-Rom Holdings (HRC) United States $6.945B 21.48
Aurora Cannabis (ACB) Canada $6.920B 49.50
Perrigo (PRGO) Ireland $6.732B 10.22
ICU Medical (ICUI) United States $5.180B 28.86
Insulet (PODD) United States $5.177B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.529B 0.00
Haemonetics (HAE) United States $4.482B 39.76
Agios Pharmaceuticals (AGIO) United States $3.370B 0.00
Hutchison China MediTech (HCM) China $3.317B 0.00
Neogen (NEOG) United States $3.262B 50.11
NuVasive (NUVA) United States $2.949B 27.43
Quidel (QDEL) United States $2.670B 24.08
National Vision Holdings (EYE) United States $2.583B 49.97
Aphria (APHA) $2.429B 107.89
AtriCure (ATRC) United States $1.267B 0.00
Phibro Animal Health (PAHC) United States $1.231B 17.70
VAREX IMAGING (VREX) United States $1.213B 23.75
Cardiovascular Systems (CSII) United States $1.191B 854.75
HEXO (HEXO) $1.180B 0.00
MacroGenics (MGNX) United States $0.936B 0.00
Cerus (CERS) United States $0.886B 0.00
PetIQ (PETQ) United States $0.833B 21.60
Surmodics (SRDX) United States $0.773B 112.39
Lantheus Holdings (LNTH) United States $0.737B 19.96
Meridian Bioscience (VIVO) United States $0.728B 21.70
Evolus (EOLS) United States $0.725B 0.00
NanoString Technologies (NSTG) United States $0.718B 0.00
OraSure Technologies (OSUR) United States $0.707B 31.16
Omeros (OMER) United States $0.681B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.624B 20.02
Quanterix (QTRX) United States $0.505B 0.00
Owens & Minor (OMI) United States $0.494B 6.84
LeMaitre Vascular (LMAT) United States $0.492B 23.46
Insys Therapeutics (INSY) United States $0.418B 0.00
TG Therapeutics (TGTX) United States $0.398B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.99
BioLife Solutions (BLFS) United States $0.322B 435.25
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.293B 0.00
Vapotherm (VAPO) United States $0.285B 0.00
Bovie Medical (APYX) United States $0.281B 0.00
Cytosorbents (CTSO) United States $0.259B 0.00
Rockwell Medical (RMTI) United States $0.253B 0.00
Zynex (ZYXI) United States $0.170B 16.42
Surface Oncology (SURF) United States $0.147B 0.00
Fonar (FONR) United States $0.146B 7.79
Chembio Diagnostics (CEMI) United States $0.116B 0.00
Chimerix (CMRX) United States $0.097B 0.00
United-Guardian (UG) United States $0.090B 18.77
Female Health (VERU) United States $0.085B 0.00
InfuSystems Holdings (INFU) United States $0.083B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.064B 17.80
Conatus Pharmaceuticals (CNAT) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Neurotrope (NTRP) United States $0.034B 0.00
Senestech (SNES) United States $0.022B 0.00
Myomo (MYO) United States $0.017B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.013B 0.00
Akers Biosciences Inc (AKER) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 14.29